These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26884383)

  • 1. Direct regulation of IGF-binding protein 1 promoter by interleukin-1β via an insulin- and FoxO-1-independent mechanism.
    Shi L; Banerjee D; Dobierzewska A; Sathishkumar S; Karakashian AA; Giltiay NV; Nikolova-Karakashian MN
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E612-E623. PubMed ID: 26884383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide- and ERK-dependent pathway for the activation of CCAAT/enhancer binding protein by interleukin-1beta in hepatocytes.
    Giltiay NV; Karakashian AA; Alimov AP; Ligthle S; Nikolova-Karakashian MN
    J Lipid Res; 2005 Nov; 46(11):2497-505. PubMed ID: 16106045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1β regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism.
    Dobierzewska A; Shi L; Karakashian AA; Nikolova-Karakashian MN
    J Biol Chem; 2012 Dec; 287(53):44749-60. PubMed ID: 23105097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
    Tang Q; Wu J; Zheng F; Hann SS; Chen Y
    Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2.
    Rutkute K; Karakashian AA; Giltiay NV; Dobierzewska A; Nikolova-Karakashian MN
    Hepatology; 2007 Oct; 46(4):1166-76. PubMed ID: 17668873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of insulin-like growth factor binding protein-1 expression during aging.
    Rutkute K; Nikolova-Karakashian MN
    Biochem Biophys Res Commun; 2007 Sep; 361(2):263-9. PubMed ID: 17645865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins.
    Mounier C; Dumas V; Posner BI
    Endocrinology; 2006 May; 147(5):2383-91. PubMed ID: 16455781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TXNDC5 contributes to rheumatoid arthritis by down-regulating IGFBP1 expression.
    Li J; Xu B; Wu C; Yan X; Zhang L; Chang X
    Clin Exp Immunol; 2018 Apr; 192(1):82-94. PubMed ID: 29131315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
    Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
    Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
    J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha) regulate insulin-like growth factor binding protein-1 (IGFBP-1) levels and mRNA abundance in vivo and in vitro.
    Benbassat CA; Lazarus DD; Cichy SB; Evans TM; Moldawer LL; Lowry SF; Unterman TG
    Horm Metab Res; 1999; 31(2-3):209-15. PubMed ID: 10226804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.
    Nov O; Kohl A; Lewis EC; Bashan N; Dvir I; Ben-Shlomo S; Fishman S; Wueest S; Konrad D; Rudich A
    Endocrinology; 2010 Sep; 151(9):4247-56. PubMed ID: 20660063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation.
    Karakashian AA; Giltiay NV; Smith GM; Nikolova-Karakashian MN
    FASEB J; 2004 Jun; 18(9):968-70. PubMed ID: 15059969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
    Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.
    Yin X; Pavone ME; Lu Z; Wei J; Kim JJ
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E35-43. PubMed ID: 22072736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.
    Kanamori Y; Murakami M; Sugiyama M; Hashimoto O; Matsui T; Funaba M
    J Biol Chem; 2017 Jun; 292(24):10275-10287. PubMed ID: 28438835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosine decreases IGFBP1 production in db/db mice through suppression of HIF-1.
    Forsberg EA; Botusan IR; Wang J; Peters V; Ansurudeen I; Brismar K; Catrina SB
    J Endocrinol; 2015 Jun; 225(3):159-67. PubMed ID: 25869614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation of FoxO1 in pancreatic β cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism.
    Fardini Y; Masson E; Boudah O; Ben Jouira R; Cosson C; Pierre-Eugene C; Kuo MS; Issad T
    FASEB J; 2014 Feb; 28(2):1010-21. PubMed ID: 24174424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a region in the human IRS2 promoter essential for stress induced transcription depending on SP1, NFI binding and ERK activation in HepG2 cells.
    Udelhoven M; Leeser U; Freude S; Hettich MM; Laudes M; Schnitker J; Krone W; Schubert M
    J Mol Endocrinol; 2010 Feb; 44(2):99-113. PubMed ID: 19755487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.